Home Wealth  Money Gilead Pays Up For Pharmasset

Gilead Pays Up For Pharmasset

Posted: Nov. 22nd, 2011  |  By Forbes

powered by Forbes

RSS Syndicated News Email a Friend Suggest an Article Share Visit Website

Gilead Sciences has agreed to acquire Pharmasset for $137 per share in cash.

The transaction values Pharmasset (nasdaq: VRUS - news - people ) at $11 billion, and is expected to be completed in the first quarter of 2012.

Pharmasset's board has approved the transaction, and Gilead (nasdaq: GILD - news - people ) said it will be accretive to earnings beginning in 2015.

Gilead said the acquisition represents an important and exciting opportunity to accelerate its effort to change the treatment paradigm for hepatitis C with all-oral regimens.

Pharmasset has three clinical-stage candidates for the treatment of chronic hepatitis C virus.

Keep an eye on shares of Regeneron Pharmaceuticals (nasdaq: REGN - news - people ) today as well.

The company said late Friday the US Food and Drug Administration has approved its EYLEA injection for the treatment of patients with neovascular age-related macular degeneration.

The treatment was approved at a dose of 2 milligrams every four weeks for the first 12 weeks, followed by 2 milligrams every eight weeks.

Market News Video produces and distributes online videos about stocks and investing.




Share on Facebook Share
See Next Article
Write a Story/Review about this topic

Post a Comment

 
Need to Get Away?
Top 10 Business Hotels
Who says you can’t mix business with pleasure?
Read More
More Articles from Forbes.com

advertisement
Quick Links
Autos
Boating
Real Estate
Luxury Travel
Fashion
Search Real Estate
Find Your Dream Home
Search for homes by
State, Country or Style.
Event Calendar
advertisement
Current News & Features
Yacht Hunting? Check Out the New Oceanis 60 Sailboat
Mercedes-Benz Future Truck 2025 Will Drive Itself
Warm Your Home (Or Just Make it Look Really Cool) with Eco-Friendly, Smoke-Free Cocoon Fireplaces
Is the SPIN Dial the Remote of the Future? We Hope So
LA Carlyle Residences Report Record Sales, $225M So Far
This is How You Elevate a Holiday Dinner Party With Perfect Table Etiquette
Aëdle Will Engrave Whatever You Want On Their VK-1 Headphones
McLaren Engineer Designs VanDutch Gocycle G2 Electric Bike
Forget Roasting Chestnuts, Whip Them Into a Tiramisu Instead
Sure You Drink It, But How Much Do You Really Know About Absolut Vodka?
See the complete list
 
Featured Photo Gallery
See the complete list
THINGS WE LIKE